Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • Guaranteed Paid Placement
  • SocialBoost
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • SocialBoost
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

The Leukemia & Lymphoma Society's 2017 Leukemia Ball, Presented by PhRMA, Celebrates 30th Anniversary with Record-Breaking $4.1 Million Raised for Cancer Cures


News provided by

The Leukemia & Lymphoma Society

Mar 22, 2017, 09:36 ET

Share this article

Share toX

Share this article

Share toX

RYE BROOK, N.Y., March 22, 2017 /PRNewswire-USNewswire/ -- As the world's leading non-profit dedicated to fighting blood cancers, The Leukemia & Lymphoma Society (LLS) has played a role in most therapies used today to treat blood cancer patients, some of which are even helping patients with other cancers and serious diseases. Such advances are possible due to LLS's significant investment in cutting-edge research – more than $1 billion in the organization's history.  That milestone continues to grow with the record-breaking sum of $4.1 million raised at the 30th annual Leukemia Ball, held March 11, in Washington, D.C.  Supported by private donations and industry, including PhRMA and other sponsors, these donations will fund blood cancer research to advance lifesaving treatments and cures, and critical patient education and support programs.

The Leukemia Ball reigns as one of Washington, D.C.'s most prestigious fundraising events, and one that demonstrates LLS's impact in the cancer arena. National TV personalities and husband and wife team Lindsay Czarniak, ESPN SportsCenter anchor, and Craig Melvin, MSNBC anchor and "Today" show correspondent, emceed the event, which featured performances by Grammy-nominated comedian Jim Gaffigan and platinum-selling artist Andy Grammer. The event, at the Walter E. Washington Convention Center, was attended by more than 1,700 guests from the business, medical, sports, philanthropic and entertainment worlds.

To showcase LLS's leadership in cancer research, a highlight of the Ball was an update of LLS's pioneering work in acute myeloid leukemia (AML), one of the deadliest blood cancers for which there has not been an advance in treatment for more than 40 years.  LLS recently launched the groundbreaking Beat AML Master Trial, which uses genomic technology to identify genetic mutations that drive the cancer so patients can be matched with more precisely targeted therapies. Beat AML lead investigator, world renowned cancer expert Brian Druker, M.D., Director, OHSU Knight Cancer Institute, has worked with LLS for more than 22 years. 

According to Louis J. DeGennaro, Ph.D., LLS President and CEO, "LLS is honored to be working with Dr. Druker, who is as passionate as we are about pushing the envelope to find cures and improve the quality of life for cancer patients and their families. With our Beat AML Master Trial, we are truly changing the paradigm for the way cancer research is done by advancing the promise of precision medicine not someday, but today."

DeGennaro continued, "Thirty years ago the survival rate for children diagnosed with acute lymphoblastic leukemia (ALL) was 10%, today it's 90%. For children diagnosed with non-Hodgkin lymphoma, we've taken the survival rate from 50% to 85%. We have made great progress but there is more work to be done.  And LLS is determined to continue to lead the charge for patients."

A moving "mission moment" featured award-wining journalist Loriana Hernandez-Aldama, who is currently battling acute myeloid leukemia (AML), with Dr. Druker. Previous to his work on Beat AML, Druker's ground-breaking LLS-funded research changed the landscape of cancer through the development of the targeted drug imatinib (Gleevec®). A treatment for chronic myeloid leukemia (CML), imatinib has helped tame one of the most lethal forms of leukemia and saved the lives of thousands of patients.

 "The Leukemia Ball is one of D.C.'s can't miss events. What's truly inspiring is how the community really came together to exceed our goals for the 30th anniversary," said Wayne Berson, Leukemia Ball Senior Co-Chair and Chief Executive Officer, BDO. "This mission is critically important and I am proud to partner with an organization that is leading the charge in changing outcomes for cancer patients."

The evening featured a special fundraising effort, in honor of former LLS National Capital Chapter Executive Director and Leukemia Ball Founder, David Timko, a two-time lymphoma survivor. Driven by some of the region's top corporate executives, C.E. Andrews, Chairman of MorganFranklin; Albert Lord, former head of Sallie Mae; Ed Quinn, Chairman of TW Perry; and Bill Shaw, Chairman of Marriott Vacations Worldwide, presented a check for $1 million to LLS in David Timko's name.

The first Leukemia Ball spearheaded by Timko raised $80,000. Since 1988, the Leukemia Ball has raised more than $59 million to support LLS's mission. Over the past 30 years, Timko has worked with countless outstanding area executives who dedicated their time, talent and treasury to advancing the mission of LLS. Knowing of David's passion for advancing blood cancer research, they thought of no greater gift than to advance research into the disease that David spent his career making progress with and fought, not once, but twice, lymphoma. 

Over the course of three decades, funds raised by LLS through the Leukemia Ball have provided hope to more than 1.2 million Americans living with blood cancer. In the DC metro region there are 25,000 people living with leukemia, lymphoma or myeloma.

The Fund the Fight portion of the evening featured Patrick Paolini, Vice President & General Manager, Fox5; Holly Morris, Anchor, Fox 5; and Morning-Show Radio Personality Loo-Katz from WASH-FM. Together they helped generate additional funds on-site, resulting in $174,000 raised in 10 minutes. The night's program included recognition of the 2017 Titan of Business & Philanthropy DLA Piper, LLP and the 2017 James L. Eichberg Lifetime Achievement Award recipients, Ed & Donna Offterdinger who have supported LLS for over 20 years and helped raise more than $12 million.

"While many blood cancers have seen an incredible increase in survival rates over the years, AML is one area that hasn't seen a change in over 40 years," said Dave DiLuigi, Leukemia Ball Co-chair and Market President, Greater Washington & Central Virginia for Wilmington Trust, N.A. "We have made great strides but the need to find cures for all blood cancers remains, and the stories shared during the Ball inspired our guests to support LLS's mission to their greatest capacity."

The festivities also included dinner, a world-class silent auction featuring incredible travel packages from Official Airlines Sponsor, American Airlines and the anticipated Mercedes-Benz raffle. Washington Area Mercedes-Benz dealers, who have been raffle sponsors of the Leukemia Ball for 20 years, have helped raised more than $7 million for LLS.

Top 2017 sponsors include: PhRMA, Presenting Sponsor; The LIUNA Charitable Foundation and C.J. Coakley CO., INC, Partners in Hope; DLA Piper, LLP, Titan of Business & Philanthropy; Jazz Pharmaceuticals, Mission Sponsor; Washington-Area Mercedes-Benz, Official Raffle Vehicle Sponsor; and American Airlines, Official Airline.

For more information on LLS or the 30th Anniversary Leukemia Ball, visit www.lls.org/nca.

About The Leukemia & Lymphoma Society

The Leukemia & Lymphoma Society® (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma and improve the quality of life for patients and their families. LLS funds lifesaving blood cancer research around the world, provides free information and support services and is the voice for all blood cancer patients seeking access to quality, affordable, coordinated care.

 Founded in 1949 and headquartered in Rye Brook, N.Y., LLS has chapters throughout the United States and Canada. To learn more, visit www.LLS.org. Patients should contact the Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 9 p.m. ET.

About The National Capital Area Chapter    

LLS has 56 U.S. chapters, and the National Capital Area Chapter is one of the highest revenue-generating chapters in the nation. The National Capital Area Chapter serves Washington D.C.; the Maryland counties of Prince George and Montgomery; and the Virginia counties of Loudoun, Fairfax, Arlington and Prince William and the city of Alexandria. More than 2,700 patients and families are served by the chapter each year.

Find us on Facebook, Twitter and Instagram @LLSNatCap #LeukemiaBall2017 #Believe2017

Contacts: 
Linda Heaney 914.821.8208 [email protected]
Alexandra Pribilovics 703.399.2905 [email protected]

SOURCE The Leukemia & Lymphoma Society

Related Links

http://www.LLS.org

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

United by Courage: Siblings Named The Leukemia & Lymphoma Society's National Student Visionaries of the Year

United by Courage: Siblings Named The Leukemia & Lymphoma Society's National Student Visionaries of the Year

Cedar and Posey Connell, a brother-sister duo from Boston, MA attending Groton School and Brooks School, have been named The Leukemia & Lymphoma...

The Leukemia & Lymphoma Society 2025 Research Grants Include Acute Leukemia in Children with Down Syndrome

The Leukemia & Lymphoma Society 2025 Research Grants Include Acute Leukemia in Children with Down Syndrome

Children with Down syndrome are up to 150 times more likely to develop acute myeloid leukemia before age 5 and yet very little research has been done ...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Biotechnology

Biotechnology

Pharmaceuticals

Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.